Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial. (Q53124033)
Jump to navigation
Jump to search
scientific article published on 10 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial. |
scientific article published on 10 September 2012 |
Statements
Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial. (English)
1 reference
Rodryg Ramlau
1 reference
Vera Gorbunova
1 reference
Tudor Eliade Ciuleanu
1 reference
Silvia Novello
1 reference
Mustafa Ozguroglu
1 reference
Tuncay Goksel
1 reference
Clarissa Baldotto
1 reference
Jaafar Bennouna
1 reference
Frances A Shepherd
1 reference
Solenn Le-Guennec
1 reference
Augustin Rey
1 reference
Vincent Miller
1 reference
Nicholas Thatcher
1 reference
Giorgio Scagliotti
1 reference
10 September 2012
1 reference
30
1 reference
29
1 reference
3640-3647
1 reference
Identifiers
1 reference